ASPG and acute lymphoblastic leukemia: Of note, recent clinical observations of patients who could not tolerate asparaginase therapy due to adverse events having poorer outcomes [8–10] also clearly demonstrated the importance of asparaginase therapy in current treatment for childhood ALL.